Immune Response After SARS-CoV-2 (COVID-19) Vaccination in a Context of Non-Hodgkin Lymphoma
Clinical trial NCT05050461 · TERMINATED
Trial details
- NCT number
- NCT05050461
- Sponsor
- Versailles Hospital
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-15
- Primary completion
- 2023-02-28
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.